FDA Approves New Drug "Gilotrif" For Patients With Non-Small Cell Lung Cancer
7/13/2013
The FDA has just approved the use of Gilotrif (afatinib) to treat patients with non-small cell lung cancer (NSCLC) who have certain epidermal growth factor receptor (EGFR) gene mutations in their tumors. Lung cancer is one of the leading cancer-killers, with an estimated 159,480 people dying from the disease this year in the U.S. alone...
Study: Women Who Survived Childhood Cancer Still Have Good Chance Of Conceiving
7/13/2013
Researchers have found that although females who survived cancer in their childhood have an increased risk of infertility, they still have a good chance of conceiving. The study, published in The Lancet Oncology, revealed that around two-thirds of women who suffered from childhood cancer become pregnant...
New Approach Could Enhance Cancer Drug Delivery
7/13/2013
Researchers have developed a concept to potentially improve delivery of drugs for cancer treatment using nanoparticles that concentrate and expand in the presence of higher acidity found in tumor cells...
Belly Fat Tied to Raised Heart and Cancer Risks
7/12/2013
Carrying too much fat around the abdomen puts people at greater risk for heart disease and cancer compared with people who have a similar body mass index (BMI) but who carry their fat in other parts of the body. So says a US study published online in the July issue of the Journal of the American College of Cardiology...
Available now, XTANDI TM (enzalutamide) has been licensed for the treatment of men with advanced prostate cancer whose disease has become resistant to first-line hormonal treatments and has progressed following docetaxel chemotherapy[i], marking an important step in managing prostate cancer, which is the most common cancer among males in the UK...
New Hope In The Fight Against Childhood Cancer
7/12/2013
Cancer Research UK scientists at the University of Southampton are seeing positive results in a pre-clinical trial that could bring treatments for a particular aggressive form of childhood cancer closer to reality. Researchers in the Antibody and Vaccine Group have developed two monoclonal antibodies (mAbs) called anti-4-1BB and anti-CD40 and investigated a third called anti-CTLA-4...
Radioimmunotherapy Deemed Safe And Effective For Lymphoma Patients
7/12/2013
A new treatment option for patients with relapsing follicular, mantle cell and other indolent B-cell lymphomas has been determined safe and feasible by researchers exploring the potential of a low energy beta-emitter radiopharmaceutical...
Excess Stomach Fat Can Elevate Heart Disease, Cancer Risk
7/12/2013
Individuals with excessive abdominal fat have a greater risk of heart disease and cancer than individuals with a similar body mass index (BMI) who carry their fat in other areas of the body, according to a study published online in the Journal of the American College of Cardiology. Death and disease risk associated with excess body weight can vary among individuals with similar BMI...
Treatment Delay In Breast Cancer Influenced By Race
7/12/2013
Different factors influence delay between diagnosis and first course of treatment for breast cancer for African-American and White women. The study used data from the Carolina Breast Cancer Study (CBCS) Phase III, a program of UNC Lineberger Comprehensive Cancer Center...
Potential Blood Test for Heart Disease Discovered
7/12/2013
Every 40 seconds, someone in the US dies of cardiovascular disease (CVD). It is the number one cause of death in the world, but researchers from the University of Nebraska Medical Center (UNMC) may have stumbled upon an easy way to predict - and maybe prevent - deaths from this common disease. Dr...